Curated Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
HCM
Curated Wealth Partners's ABBV Position: Q2 2026 in Review
Curated Wealth Partners increased its AbbVie (ABBV) stake by 17,090% in Q2 2026, buying an estimated $77.8M and bringing the position to 363,902 shares worth $1.59M. The position accounts for 0.21% of the portfolio, ranked #88.
Curated Wealth Partners first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. 1,645 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Curated Wealth Partners held 363,902 shares of AbbVie worth $1.59M as of Q2 2026.
- Curated Wealth Partners bought 361,785 AbbVie shares in Q2 2026, an estimated $77.8M.
- AbbVie made up 0.21% of Curated Wealth Partners's portfolio in Q2 2026, its #88 holding.
- Curated Wealth Partners first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
- 1,645 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.